Login to Your Account

Fortunerock raises $24M for new subsidiary, IPO

By Cornelia Zou
Staff Writer

Wednesday, August 27, 2014

HONG KONG – A Chinese protein drug developer received a $24 million investment to prepare a new subsidiary and pave the way for an initial public offering (IPO).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription